Compare Johnson & Johnson (JNJ) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Johnson & Johnson trades at $251.01 (market cap $598.96B), while KraneShares Electric Vehicles and Future Mobility trades at $29.85. The key difference: Johnson & Johnson pays a 2.15% dividend while KraneShares Electric Vehicles and Future Mobility pays none, and Johnson & Johnson is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.
| JNJ | KARS | |
|---|---|---|
Market Cap | $598.96B | — |
Volume | 6,156,228 | — |
Sector | Health | Sector/Thematic |
52-Week High | $267.24 | $38.01 |
52-Week Low | $164.36 | $23.61 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
KARS trades at $29.15, down 0.98% with bearish technical signals across moving averages and oscillators. The stock shows oversold conditions with RSI at 27.23, while facing resistance at $30. Recent industry news highlights strong global EV sales growth and China's expanding market presence, though US adoption lags behind international markets.
The EV sector faces competitive pressures from Chinese manufacturers and regulatory uncertainty, while benefiting from rising fuel prices driving consumer demand. KARS's performance depends on broader industry trends rather than company-specific fundamentals, with technical indicators suggesting continued near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
